NASDAQ

Updated Oct 30, 7:59 PM ET

IMRX

Immuneering Corporation Class A

−$0.28 (6.84%) Fri · Closed $3.75

−$0.02 (0.56%) ☾ After Hours

Oct 30, 7:59 PM ET

About IMRX

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Why it moved

Moved with Pharmaceuticals peers: SDGR −9.50% · BHC −7.97% · PTCT −6.97%

From market data · Not investment advice

Sign up free to see this.

Daily pricesFundamentals

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

Votes and Bull · Bear posts, 24h. At least 5 are needed.

How do you feel about IMRX?

Board · 0 threads

Open board ›

Community opinions, not advice. Posts with a target get a receipt. How receipts work ›